leukemia National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support u.s. gov't adult female male aged middle aged Remission Induction Prospective Studies P.H.S. Clinical Trial Phase III Randomized Controlled Trial Double-Blind Method Multicenter Study length of stay acute disease Survival Analysis neutropenia / chemically induced combined modality therapy antineoplastic combined chemotherapy protocols / adverse effects cytarabine / administration & dosage disease-free survival recombinant proteins / therapeutic use myeloid / drug therapy antineoplastic combined chemotherapy protocols / therapeutic use p h wiernik immunologic factors / therapeutic use* pmid:7605984 j m rowe j w andersen bone marrow examination cytarabine / adverse effects daunorubicin / administration & dosage daunorubicin / adverse effects granulocyte-macrophage colony-stimulating factor / therapeutic use* myeloid / mortality myeloid / therapy* neutropenia / therapy*